• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

APPENDIX B - FY 2000 OST Presentations

October 1, 1999 – September 30, 2000

Alqahtani J, McLean I, Weiblinger R, Ediger M. Corneal ablation with low fluence excimer laser. Presented at AAO Annual Meeting, Orlando, FL, October 24-27, 1999.

Beer JZ, Bushar HF, Chwirut DJ, Ediger MN, Lee W, Matchette LS, Miller SA, Lopez H, Weininger S, Zmudzka BZ. How to measure UV response in human skin? 2000 FDA Science Forum, FDA and the Science of Safety: New Perspectives, Washington, DC, February 14-15, 2000.

Beer JZ, Hearing VJ. UV or not UV, that is the question. National Cancer Institute, Bethesda, MD, June 20, 2000.

Brown SA. On methods used for corrosion testing of NiTi. Shape Memory and Superelastic Technologies, Pacific Grove, CA, April 2000.

Brown SA, Merritt K, Woods TO, Hitchins VM. The effects of use and simulated reuse on PTCA balloons and catheters. Transactions of the 6th World Congress of Biomaterials, Kamuela, HI, p. 462, May 19, 2000.

Bushar GS, Lyle DB, Langone JJ. Development of a standard methodology for screening medical device materials for alternative pathway complement activation. Immunology 2000, Seattle, WA, May 12-16, 2000.

Byrnes GA, Miller SA, Mazur DO, Grossman LW. Laser characteristics through fundus contact treatment lenses: risk potential for anterior segment complications, presented at Annual Meeting of Association for Research in Vision and Ophthalmology (ARVO), Ft. Lauderdale, FL, April 6 - May 4, 2000.

Chwirut DJ. General interest members perspective on Committee F4 Standards. Workshop on Past, Present, and Future, ASTM Committee F04, Toronto, Canada, May 2000.

Elespuru RE. Summary principles and case studies: CDER genetic toxicology course, Rockville, MD, June 14, 2000.

Elespuru RE. Genetic toxicology: CDRH biocompatibility course, Gaithersburg, MD, May 17, 2000.

Elespuru RE. In vitro p53 mutagenicity assay for use in cancer risk assessment. FDA Science Forum poster presentation, Washington, DC, February 14, 2000.

Elespuru RE. The background and principles of genetic toxicology testing. CDER Genetic Toxicology Course, April 26, 2000.

Ediger MN. Emerging technologies in biomedical optics. Presented at National Research Council, Washington, DC, January 4, 2000.

Ediger MN. Optical diagnostic medical devices - considerations for clinical trials and market clearance in the US. Presented at Shedding New Light on Disease: Optical Diagnostics for the Millennium, NRC Canada, Winnipeg, Canada, June 26, 2000.

Godar DE. Full-spectrum apoptosis: vive la difference. International Congress of Photobiology (ICP), San Francisco, CA, July 2000.

Godar DE. UVA1 radiation triggers two different final apoptotic pathways. 13th International Congress on Photobiology, San Francison, CA, July 1-6, 2000.

Heaton HT, Phillips RA. FDA and brachytherapy sources. AAPM North Central Chapter, Madison, WI, October 7, 1999.

Heaton HT. MPDs for the NEEDs 3 report - possible new programs. Eighth Annual Meeting of the Council of Ionizing Radiation Measurements and Standard, National Institute of Standards and Technology, Gaithersburg, MD, October 13-15, 1999.

Heaton HT. Overview of the medical subcommittee activities. Eighth Annual Meeting of the Council of Ionizing Radiation Measurements and Standard, National Institute of Standards and Technology, Gaithersburg, MD, October 13-15, 1999.

Heaton HT. FDA X-ray calibration laboratory: traceability to national standards. 33d HPS Mid-Year Symposium, Virginia Beach, VA, January 30 - February 2, 2000.

Heaton HT. IDE and PMA dosimetry issues, Cardiovascular Radiation Therapy IV, Washington, DC, Feb 16-18, 2000.

Hellman KB. FDA Perspectives: biologics and devices. Update of FDA TSE Working Group Initiatives, Cambridge Healthtech Institute Conference on Transmissible Spongiform Encephalopathies, October 1999 (abstract).

Hellman KB. FDA perspectives: biologics and devices – update of FDA TSE working group initiatives, Cambridge Healthtech Institute (CHI) Conference on Transmissible Spongiform Encephalopathies (TSEs), Washington, DC, October 27-28, 1999.

Hellman KB. U.S. FDA Regulatory Initiatives for Tissue Engineered Medical Products. AIST-MITI – University of Tokyo Joint Workshop on Industrialization of Tissue Engineering, Tokyo, Japan, March 21, 2000.

Hellman KB. Tissue engineering: the regulatory perspective. Pittsburgh Orthopedic Tissue Engineering Symposium, Pittsburgh, PA, April 16-19, 2000.

Hellman KB. Review of tissue engineering in the United States. MATES and U.S. Government Tissue Engineering Initiative, WTEC Workshop, Bethesda, MD, June 5-6, 2000.

Hellman KB. Introduction to MATES and survey of FDA tissue engineering initiatives. FDA MATES Working Group Meeting, Tissue Engineering, Gaithersburg, MD, June 15, 2000.

Hellman KB. Overview and future perspectives, DARPA Focus 2000, Science/Technology at FDA, Chantilly, VA, June 29-30, 2000.

Hellman KB. Reference data on properties of biomaterials. Tissue Engineering Biomaterials, National Institute of Standards and Technology Workshop, Gaithersburg, MD, July 29, 2000.

Hellman KB. Regulatory issues for tissue engineering. Functional Tissue Engineering Workshop, Tampa, Fl, September 14-19, 2000.

Howard PC, Sams II RL, Miller BJ, Allaben WT, Okerberg C, Bucci TJ, Wamer WG, Beer JZ. Response of SKH-1 mouse skin simulated solar and UV radiation. 2000 FDA Science Forum, FDA and the Science of Safety: New Perspectives, Washington, DC, February 14-15, 2000.

Ilev IK, Waynant RW. Fiber optic based confocal microscope with submicron resolution. Presented at Optical Imaging Workshop, National Institutes of Health, Bethesda, MD, Sep 7, 2000.

Ilev IK, Waynant RW. Ultraviolet visible and infrared laser delivery using laser-to-fiber coupling via a grazing incidence-based hollow taper. Presented at European Symposium on BIOS: Europe (EUROPTO, EBIOS-2000), Amsterdam, July 4-8, 2000.

Ilev IK, Waynant RW. Submicron reflection confocal microscope with multimode fiber output. Presented at Conference of Lasers and Electro Optics (CLEO), San Francisco, CA, May 7-14, 2000.

Beer JZ, Bushar HF, Busick D, Chwirut DJ, Cyr WH, Ediger MN, Lao NT, Matchette LS, Miller SA, Lopez H, Weininger S, Zmudzka BZ. Studies on parameters of UV response in human skin: a progress report. 13th International Congress on Photobiology, San Francisco, July 1-6, 2000.

Lightfoote MM, Bushar GS, Langone JJ. Immunological responses to silicone breast implants. Innate Immunity Workshop, Aegean Conferences, Santorini, Greece, October 11-15, 2000.

Lightfoote MM, Bushar GS, Langone JJ. Immunological responses to silicone breast implants. Lymphocyte Signaling, Aegean Conferences, October 16-20, 2000, Santorini, Greece.

Luu HMD, Hutter JC. Poster presentation: A physiologically based pharmacokinetic modeling of octamethylcyclostetrasiloxane (D4). American Chemical Society, San Francisco, CA, April 2000.

Lyle DB, Bushar GS, Langone JJ. Development of a standard methodology for screening medical device materials for alternative pathway complement activation. Proceedings, FDA Science Forum, Washington, DC, February 14-15, 2000.

Miller SA, Zmudzka BZ, Matchette LS, Beer JZ. Ultraviolet radiation exposure from diagnostic medical devices – preliminary evaluation of acute risks. Presented at International Workshop on UV Radiation Exposure, Measurement, and Protection, Oxford, UK, Oct 18-20, 1999.

Owen RD. Biological effects and health consequences of RF fields. 4th International Non-Ionizing Radiation Workshop, International Commission on Non-Ionizing Radiation Protection, Kyoto, Japan, June 24, 2000.

Owen RD. The biological effects of ELF-EMF and the results of US research. Symposium on Electromagnetic Fields and Health, Agency of National Resources and Energy (ANRE) of the Japanese Ministry of International Trade and Industries (MITI) and Japan Electrical Safety & Environment Technology Laboratories, Tokyo, Japan, June 19 2000.

Royston DD. Laser sources in TMLR and PMR: effects and performance measurements. Presented at Workshop on Cardiovascular Applications of Lasers, FDA, Center for Veterinary Medicine, Laurel, MD, May 9-10, 2000.

Schroeder LW. Packaging medical products made of natural rubber latex. Conference on Medical Packaging, Center for Business Intelligence, Washington, DC, December 10-11, 1999.

Shope TB. Perspectives on radiation injuries from fluoroscopy. World Congress on Medical Physics and Biomedical Engineering (Introduction to Refresher Course on "Injuries from Fluoroscopy, What They Are, Why They Occur and How to Avoid Them"), Chicago, IL, July 27, 2000.

Silberberg JL, Boyd SM, Heirman DN. On-site medical device immunity testing (seminar and workshop on ANSI C63.18), sponsored by the US EMC Standards Corporation and the University of Oklahoma Center for the Study of Wireless EMC, Walter Reed Army Medical Center, Washington, DC, November 8-9, 1999.

Silberberg JL. Update on the draft second edition of international standard IEC 60601-1-2 for EMC of medical electrical equipment. 2000 IEEE International Symposium on EMC, Washington, DC, August 21-25, 2000.

Tadokoro T, Kobayashi N, Beer JZ, Zmudzka BZ, Korossy KS, Hearing VJ. Examination of DNA damage induced by ultraviolet irradiation of human skin within racial/ethnic groups. 9th Meeting of the European Society for Pigment Cell Research, Ulm, Germany, September 27-October 1, 2000.

The Photosciences Network (with contributors in CDER, CDRH, CFSAN, NCTR and NCI/NIH). Quantitative, biologically relevant parameters for testing and standardization of skin response to UV. 2000 FDA Science Forum, FDA and the Science of Safety: New Perspectives, Washington, DC, February 14-15, 2000.

Wear KA. A model for ultrasonic backscatter from trabecular bone. 1999 IEEE Ultrasonics Symposium, Lake Tahoe, CA, October 17-21, 1999.

Wear KA. Comparison of phase and group velocities in trabecular bone,Proceedings of the 25th International Symposium on Ultrasonic Imaging and Tissue Characterization, Arlington, VA, May 22-24, 2000.

Wear KA. Variations in transit-time-based ultrasonic velocity estimates in human calcaneus due to frequency-dependent attenuation and dispersion, Proceedings of the SPIE Medical Imaging 2000 Conference, San Diego, CA, February 12-17, 2000.

Wear KA. Fundamental mechanisms underlying broadband ultrasonic attenuation and backscattering in calcaneus. American Society of Bone and Mineral Research 22nd Annual Meeting, Toronto, Ontario, Canada, September 22 - 26, 2000. Received award for fifth place poster (out of 37) in ultrasound category.

Wear KA. Sources of disparity for transit-time-based and frequency-domain-based sound speed measurements in trabecular bone. Amer. Soc. Bone Min. Res. 22nd Annual Meeting, Toronto, Ontario, Canada, September 22 - 26, 2000.

Witters DM. Planning for the future: addressing electromagnetic interference (EMI) risks with the new dedicated wireless medical telemetry service. NCHES 4th Annual Conference "Ending the Millennium," National Capital Healthcare Engineering Society (NCHES), Bethesda, MD, May 2, 2000.

Zmudzka BZ, Lao NT, Miller SA, van der Leun JC, Beer JZ. UV-induced erythema vs. skin type and race/ethnicity: visual and instrumental explorations. 13th International Congress on Photobiology, San Francisco, July 1-6, 2000.